LianMedical (LIANY)
OTCMKTS · Delayed Price · Currency is USD
0.0379
-0.0111 (-22.65%)
Sep 15, 2026, 3:19 PM EST
LianMedical Market Cap
LianMedical has a market cap or net worth of $6.44 million as of September 16, 2026. Its market cap has increased by 9.78% in one year.
Market Cap
6.44M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
ChartMarket Cap Chart
Since November 1, 2021, LianMedical's market cap has decreased from 1.44B to 6.44M, a decrease of -99.55%. That is a compound annual growth rate of -67.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 6.44M | -37.37% |
| Dec 31, 2025 | 10.28M | -64.15% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
| Nov 1, 2021 | 1.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Institute of Biomedical Research | 7.97M |
| Curative Biotechnology | 7.15M |
| OSR Health | 7.06M |
| Reviva Pharmaceuticals Holdings | 7.01M |
| Hepion Pharmaceuticals | 6.93M |
| Adaptimmune Therapeutics | 6.00M |
| TRON Group | 5.52M |
| Emmaus Life Sciences | 4.79M |